HyodoI, AmanoN, EguchiK, et al.Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol, 2005; 23:2645–2654.
2.
FerrucciLM, McCorkleR, SmithT, et al.Factors related to the use of dietary supplements by cancer survivors. J Altern Complement Med, 2009; 15:673–680.
3.
MarianMJ. Dietary supplement commonly used by cancer survivors: Are there any benefits?. Nutr Clin Pract, 2017; 32:607–627.
4.
AlsanadSM, WilliamsonEM, HowardRL. Cancer patients at risk of herb/food supplement-drug interactions:a systematic review. Phytother Res, 2014; 28:1749–1755.
5.
Ben-AryeE, SamuelsN, GoldsteinLH, et al.Potential risks associated with traditional herb medicine use in cancer care: A study of middle Eastern oncology health care professionals. Cancer, 2016; 122:598–610.
6.
Ramos-EsquivalA, Víquez-Jaikel Á, FernándezC. Potential drug-drug and herb-drug interactions in patients with cancer: A prospective study of medication surveillance. J Oncol Pract, 2017; 13:e613–e622.
7.
DavisEL, OhB, ButowPN, et al.Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: A systematic review. Oncologist, 2012; 17:1475–1481.
8.
LeeRT, BarboA, LopezG, et al.National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. J Clin Oncol, 2014; 32:4095–4101.
